Cargando…
Bleeding events among patients concomitantly treated with direct oral anticoagulants and macrolide or fluoroquinolone antibiotics
Fluoroquinolones and macrolides may, due to a potential drug‐drug interaction, increase the concentration of any concomitantly administered direct oral anticoagulant (DOAC) and thereby increase the risk of severe bleeding. However, clinical evidence for such an effect is scarce. The present study ai...
Autores principales: | Yagi, Tatsuya, Mannheimer, Buster, Reutfors, Johan, Ursing, Johan, Giunta, Diego Hernan, Kieler, Helle, Linder, Marie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092847/ https://www.ncbi.nlm.nih.gov/pubmed/36098510 http://dx.doi.org/10.1111/bcp.15531 |
Ejemplares similares
-
Bleeding and thromboembolism due to drug-drug interactions with non-vitamin K antagonist oral anticoagulants—a Swedish, register-based cohort study in atrial fibrillation outpatients
por: Holm, Johan, et al.
Publicado: (2020) -
Synergistic anti-Campylobacter jejuni activity of fluoroquinolone and macrolide antibiotics with phenolic compounds
por: Oh, Euna, et al.
Publicado: (2015) -
Increasing Macrolide and Fluoroquinolone Resistance in Mycoplasma genitalium
por: Murray, Gerald L., et al.
Publicado: (2017) -
Risks of adverse pregnancy and birth outcomes in women treated or not treated with mood stabilisers for bipolar disorder: population based cohort study
por: Bodén, Robert, et al.
Publicado: (2012) -
Prevalence of potential drug-drug interactions in Swedish pediatric outpatients
por: Holm, Johan, et al.
Publicado: (2019)